None
Quote | Direxion Daily Healthcare Bull 3X Shares (NYSE:CURE)
Last: | $103.14 |
---|---|
Change Percent: | 0.91% |
Open: | $102.78 |
Close: | $102.2087 |
High: | $104 |
Low: | $102.195 |
Volume: | 48,167 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
News | Direxion Daily Healthcare Bull 3X Shares (NYSE:CURE)
2024-02-08 12:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-01-17 14:00:00 ET Summary JD Henning discusses his approach to the market and emphasizes the importance of timing and using momentum gauges to avoid major market downturns. Investing vs trading portfolios. Henning advises caution in the current market and suggests focusin...
Message Board Posts | Direxion Daily Healthcare Bull 3X Shares (NYSE:CURE)
Subject | By | Source | When |
---|---|---|---|
Manage > Home > Boards > Other Markets | JohnCM | investorshub | 03/06/2020 10:47:57 PM |
When this sucker runs, it runs! | JohnCM | investorshub | 03/06/2020 9:58:26 PM |
$CURE is in play! | JohnCM | investorshub | 03/04/2020 6:31:13 PM |
In play Monday morning. | JohnCM | investorshub | 03/01/2020 5:08:27 PM |
IN PLAY!! | JohnCM | investorshub | 02/29/2020 4:41:43 PM |
News, Short Squeeze, Breakout and More Instantly...
Direxion Daily Healthcare Bull 3X Shares Company Name:
CURE Stock Symbol:
NYSE Market:
2024-02-08 12:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-12-01 02:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Vancouver, British Columbia--(Newsfile Corp. - September 18, 2023) - Biocure Technology Inc. (CSE: CURE) ("CURE" or the "Company") announces that it has entered into an exclusive letter agreement dated September 8, 2023 with Atriva Therapeutics GmbH. ("Atriva") whereby the Company will acquire al...